DekaBank Deutsche Girozentrale’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-15,000
Closed -$1.04M 1229
2025
Q4
$1.04M Hold
15,000
﹤0.01% 872
2025
Q3
$508K Hold
15,000
﹤0.01% 985
2025
Q2
$461K Hold
15,000
﹤0.01% 996
2025
Q1
$434K Hold
15,000
﹤0.01% 993
2024
Q4
$427K Hold
15,000
﹤0.01% 1030
2024
Q3
$462K Hold
15,000
﹤0.01% 1029
2024
Q2
$498K Hold
15,000
﹤0.01% 1006
2024
Q1
$932K Hold
15,000
﹤0.01% 892
2023
Q4
$1.01M Hold
15,000
﹤0.01% 897
2023
Q3
$756K Hold
15,000
﹤0.01% 931
2023
Q2
$851K Hold
15,000
﹤0.01% 914
2023
Q1
$698K Buy
+15,000
New +$843K ﹤0.01% 950

Other funds holding IMCR

DekaBank Deutsche Girozentrale's IMCR Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Immunocore (IMCR) in Q1 2026, closing a stake of 15,000 shares — an estimated $1.04M sold.

DekaBank Deutsche Girozentrale first reported a position in IMCR in Q1 2023 and held it in 12 quarters. The position peaked at $1.04M in Q4 2025. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • DekaBank Deutsche Girozentrale reported no remaining Immunocore position as of Q1 2026 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 15,000 Immunocore shares in Q1 2026, an estimated $1.04M.
  • DekaBank Deutsche Girozentrale first reported a position in Immunocore in Q1 2023 and held it in 12 quarters.
  • DekaBank Deutsche Girozentrale's Immunocore position peaked at $1.04M in Q4 2025.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.